Global Artificial Blood Vessels Market Size, Share, and COVID-19 Impact Analysis, By Polymer Type (Polydioxanone, Elastomer, Polyethylene Terephthalate, and Others), By End-users (Hospitals, Cardiac Catheterization Laboratories, Ambulatory Surgical Centers, Specialty Clinics, and Others), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Global Artificial Blood Vessels Market Insights Forecasts to 2035

• The Global Artificial Blood Vessels Market Size Was Estimated at USD 2.21 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of around 5.2% from 2025 to 2035
• The Worldwide Artificial Blood Vessels Market Size is Expected to Reach USD 3.86 Billion by 2035
• Asia Pacific is expected to grow the fastest during the forecast period.

According to a research report published by Spherical Insights and Consulting, The Global Artificial Blood Vessels Market Size was worth around USD 2.21 Billion in 2024 and is predicted to grow to around USD 3.86 Billion by 2035 with a compound annual growth rate (CAGR) of 5.2% from 2025 to 2035. The market for artificial blood vessels is increasing with the rising number of cases of cardiovascular diseases and vascular disorders, an aging and large population, and advances in biomaterials and 3D printing. Higher demand for vascular grafts in bypass operations and for peripheral artery disease treatment, combined with innovations improving graft durability and biocompatibility, are major market drivers.

Global Artificial Blood Vessels Market Forecast and Revenue Outlook

• 2024 Market Size: USD 2.21 Billion
• 2035 Projected Market Size: USD 3.86 Billion
• CAGR (2025-2035): 5.2%
• North America: Largest market in 2024
• Asia Pacific: Fastest growing market

Market Overview

The market of artificial blood vessels refers to the use of engineered conduits to replace or bypass compromised blood vessels and is used in cardiovascular procedures, such as coronary artery bypass grafting, treatment of peripheral arterial diseases, and vascular access for dialysis. The vessels are created from synthetic polymers, tissue-engineered materials, or hybrids and target the increasing demand for successful vascular repair. The market is growing with the increasing prevalence of cardiovascular diseases across the globe, demographic factors such as a growing aging population, lifestyle risk factors such as diabetes and hypertension, and advancements in biomaterial technology that improve the longevity and biocompatibility of the graft.

Emerging economies such as the Asia Pacific and Latin America are good opportunities, fuelled by increased healthcare facilities and disease consciousness. Technological innovations such as 3D printing and bioengineered grafts also fuel the market growth. W. L. Gore & Associates, Terumo Corporation, Medtronic, B. Braun Melsungen, and Getinge AB are the major players who spend relentlessly on product development. Governments worldwide are encouraging the sector through regulatory revolution, research funding, and approval of domestically produced products, most prominently the Healthy China 2030 initiative in China and South Korea's investment in AI-driven vascular technologies.

Key Market Insights

• North America is expected to account for the largest share in the artificial blood vessels market during the forecast period.
• In terms of polymer type, the polyethylene terephthalate segment is projected to lead the artificial blood vessels market throughout the forecast period
• In terms of end-users, the hospitals segment captured the largest portion of the market

Artificial Blood Vessels Market Trends

• The rise of 3D printing technology enables customized and patient-specific vascular grafts.
• Increasing prevalence of cardiovascular diseases is driving demand for artificial blood vessels globally.
• Integration of AI and nanotechnology is improving the development of next-generation vascular grafts.
• Advancements in biomaterials and tissue engineering are improving graft durability and biocompatibility.
• Growing healthcare infrastructure in emerging markets is expanding market opportunities.

Report Coverage

This research report categorizes the artificial blood vessels market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyzes the key growth drivers, opportunities, and challenges influencing the artificial blood vessels market. Recent market developments and competitive strategies, such as expansion, type launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyzes their core competencies in each sub-segment of the artificial blood vessels market.

Driving factors

The artificial blood vessel market grows due to more cardiovascular diseases, minimally invasive surgeries, and advances in biomaterials and 3D printing. The artificial blood vessel market is expanding as the number of cardiovascular disease cases rises globally, increasing the need for effective vascular treatments. At the same time, minimally invasive surgeries are becoming more common because they reduce recovery time and complications, driving demand for advanced grafts suited to these procedures. Additionally, continuous advancements in biomaterials improve vessel compatibility and durability, while 3D printing enables customized, precise grafts, collectively boosting market growth.

Restraining Factor

The artificial blood vessels market is restrained by high costs, regulatory hurdles, and graft rejection risks. High manufacturing costs limit accessibility and affordability, while stringent regulatory approvals delay product launches. Additionally, risks such as graft rejection, infection, or failure hinder widespread adoption, collectively restraining the growth of the global artificial blood vessels market.

Market Segmentation 

The global artificial blood vessels market is divided into polymer type and end-users.

Global Artificial Blood Vessels Market, By Polymer Type:

• The polyethylene terephthalate segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period.  

Based on polymer type, the global artificial blood vessels market is segmented into polydioxanone, elastomer, polyethylene terephthalate, and others. Among these, the polyethylene terephthalate segment dominated the market in 2024 and is projected to grow at a substantial CAGR during the forecast period. The polyethylene terephthalate market is dominated owing to its superior mechanical strength, biocompatibility, and durability. These factors render it perfect for artificial blood vessels, which have been driving the demand and are anticipated to experience significant growth over the forecast period, as they satisfy both clinical and manufacturing needs efficiently.

The elastomer segment in the artificial blood vessels market is expected to grow at the fastest CAGR over the forecast period. The elastomer segment of the artificial blood vessels market will witness the highest CAGR during the forecast period based on its superior elasticity, biocompatibility, and versatility in different applications of vascular grafts.

Global Artificial Blood Vessels Market, By End-users:

• The hospitals segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

Based on end users, the global artificial blood vessels market is segmented into hospitals, cardiac catheterization laboratories, ambulatory surgical centers, specialty clinics, and others. Among these, the hospitals segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The hospitals segment is the dominant one due to the rise in cardiovascular disease cases that need to be treated surgically. Hospitals also provide superior healthcare infrastructure, professional operators, and advanced facilities, which make them the first preference for complicated surgeries involving artificial blood vessels, hence fueling the market further.

The ambulatory surgical centers segment in the artificial blood vessels market is expected to grow at the fastest CAGR over the forecast period. The ambulatory surgical centers segment shall record the highest growth rate, due to increased demand for affordable, convenient outpatient procedures and technology developments in minimally invasive vascular surgery.

Regional Segment Analysis of the Global Artificial Blood Vessels Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America Artificial Blood Vessels Market Trends

North America is expected to hold the largest share of the global artificial blood vessels market over the forecast period.

The global artificial blood vessels market is anticipated to be dominated by North America throughout the forecast period, as the region boasts a well-developed healthcare infrastructure, a high incidence of cardiovascular diseases, and a strong focus on innovative medical technologies. Moreover, high research and development investments, positive government policies, and extensive usage of minimally invasive surgical procedures improve market growth. The availability of strong market players and growing health awareness also aid in this dominance.

U.S. Artificial Blood Vessels Market Trends

The U.S. artificial blood vessels market is growing due to a high prevalence of cardiovascular diseases, advanced healthcare infrastructure, strong presence of key market players, and increasing adoption of innovative, minimally invasive vascular treatment technologies.

Asia Pacific Artificial Blood Vessels Market Trends

Asia Pacific is expected to grow at the fastest CAGR in the artificial blood vessels market during the forecast period. Asia Pacific is rapidly growing in the artificial blood vessels market due to urbanization and changing lifestyles at a rapid rate, which has resulted in a growing incidence of cardiovascular conditions in the region. Also, enhanced healthcare infrastructure, rising healthcare spending, and increasing awareness concerning advanced medical treatment are bolstering market demand. Availability of a large patient base, supportive government policies, and growing medical device manufacturing capacities are also key factors. In addition, increasing use of minimally invasive procedures and advancements in technology further drive market growth in the Asia Pacific region.

India Artificial Blood Vessels Market Trends

India's market for artificial blood vessels is expanding due to the growing prevalence of cardiovascular disease, enhanced healthcare facilities, increased adoption of advanced surgical methods, the government's promotional policies for medical innovation, and enhanced affordability and accessibility of vascular grafts in urban and rural India.

China Artificial Blood Vessels Market Trends

China's artificial blood vessels market is expanding with the increase in cardiovascular disease cases, government incentives through Healthy China 2030 and other initiatives, improvements in medical technology, higher healthcare expenditure, and domestic-made artificial blood vessels' approval, driving market adoption.

Japan Artificial Blood Vessels Market Trends

Japan's artificial blood vessels market is expanding owing to improved robotics and nanotechnology, a population with more elderly people and rising cardiovascular diseases, robust healthcare infrastructure, support from the government for medical innovation, and increasing adoption of minimally invasive surgeries, improving treatment and demand in the market.

Europe Artificial Blood Vessels Market Trends

Europe's market for artificial blood vessels is expanding due to a high incidence of cardiovascular diseases and a well-developed healthcare infrastructure. Government support for medical research is strong, rising acceptance of new biomaterials and expanding awareness of minimally invasive surgical procedures all play an important role. Technological advancements and the presence of dominant market players also fuel market growth throughout the region throughout the forecast period.

Germany Artificial Blood Vessels Market Trends

Germany's artificial blood vessels industry is expanding owing to pioneering bioengineering research, robust healthcare infrastructure, government initiatives for medical innovations, and expanding adoption of tissue engineering grafts for improved cardiovascular therapies.

U.K. Artificial Blood Vessels Market Trends

The U.K. artificial blood vessels industry is expanding, attributed to rising cardiovascular disease cases, growing healthcare investments, biomaterials advancements, government initiatives for medical research, and expanding adoption of minimally invasive vascular surgeries.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global artificial blood vessels market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

Worldwide Top Key Players In The Artificial Blood Vessels Market Include

• B. Braun Melsungen AG
• Terumo Medical Corporation
• Becton, Dickinson and Company (BD)
• W. L. Gore & Associates, Inc.
• Artivion, Inc.
• Humacyte Inc.
• Getinge AB
• Jotec GmbH
• Abbott Laboratories
• Cook Medical Incorporated
• Medtronic Inc.
• Techshot Inc.
• LeMaitre Vascular, Inc.
• Others  

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent development

• In September 2025, B. Braun SE announced the full acquisition of True Digital Surgery, a Goleta-based company specializing in digital robotic-assisted 3D surgical microscopy, reinforcing B. Braun’s commitment to advancing digital microsurgery and expanding its market presence in this innovative field.
• In December 2024, BD and Babson Diagnostics announced expanding fingertip blood collection and testing technologies for U.S. health systems, urgent cares, doctor offices, and ambulatory care settings to enhance diagnostic capabilities and patient care.
• In December 2024, Humacyte, Inc. announced FDA full approval for SYMVESS, a bioengineered vascular conduit for adults with extremity arterial injuries needing urgent revascularization when autologous vein grafts aren’t feasible, to prevent imminent limb loss.
• In November 2024, Terumo Blood and Cell Technologies launched its Global Therapy Innovations unit, led by Veerle d Haenens, to enhance patient care by integrating disease expertise across cell collection, manufacturing, and therapy delivery for coordinated, advanced treatment standards.
• July 2, 2024, Getinge launched Pulsiocare, an advanced hemodynamic monitoring platform with CE certification, featuring an intuitive interface for enhanced patient monitoring and hemodynamic assessment.
• In October 2023, Abbott launched its vascular imaging platform powered by Ultreon 1.0 Software in India, combining optical coherence tomography (OCT) and AI to provide physicians with detailed insights into coronary artery blood flow and blockages.

Market Segment

This study forecasts revenue at the global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the artificial blood vessels market based on the following segments:

 Global Artificial Blood Vessels Market, By Polymer Type

• Polydioxanone
• Elastomer
• Polyethylene Terephthalate
• Others

Global Artificial Blood Vessels Market, By End-users

• Hospitals
• Cardiac Catheterization Laboratories
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

Global Artificial Blood Vessels Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa